An observational study in Diabetic Nephropathy Type 2 and Type 2 Diabetes Mellitus, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Assiut University · Observational
This cross-sectional study aims to evaluate serum beta-2-trace protein levels in patients with diabetic nephropathy compared with healthy controls.
Diabetic nephropathy is a major complication of type 2 diabetes mellitus. Beta-2-trace protein is a low-molecular-weight glycoprotein that is freely filtered by the glomerulus and has been proposed as a marker of kidney function.
This observational study will measure serum beta-2-trace protein by enzyme-linked immunosorbent assay in adult patients with diabetic nephropathy and healthy controls, and will also assess estimated glomerular filtration rate and other routine laboratory parameters.
9,618 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,340 are open to participants now.
This study's planned enrollment of 80 is below the median of 300 across 1,628 observational studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Assiut University is the lead sponsor of 5,071 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult patients aged 18 years or older with diabetic nephropathy and age-matched healthy controls attending Assiut University Hospitals.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adult patients with type 2 diabetes mellitus and documented diabetic nephropathy.
Apparently healthy adults without diabetes or kidney disease.
Serum beta-2-trace protein level
Mean serum beta-2-trace protein concentration measured by enzyme-linked immunosorbent assay.
Time frame: Baseline
Estimated glomerular filtration rate
Mean estimated glomerular filtration rate calculated by the CKD-EPI 2021 equation in milliliters per minute per 1.73 square meters.
Time frame: Baseline
Serum creatinine
Mean serum creatinine level in milligrams per deciliter.
Time frame: Baseline
Urine albumin-to-creatinine ratio
Mean urine albumin-to-creatinine ratio in milligrams per gram.
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.